期刊文献+

VerifyNow和Multiplate两种血小板功能检测方法对急性冠脉综合征患者的预测价值 被引量:1

Predictive value of two methods of platelet function detection for VerifyNow and Multiplate in patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨两种快速床旁检测血小板功能的方法Multiplate和VerifyNow技术对急性冠脉综合征(ACS)患者不良心血管事件的预测价值。方法分别应用VerifyNow和Multiplate技术检测ACS患者的血小板反应性,探讨血小板反应性与主要不良心血管事件(MACE,由全因死亡、非致死性心肌梗死、非致死性卒中、支架内血栓形成和血运重建组成的复合终点)之间的关系。结果对120例ACS患者随访1年后,MACE 18例(15%)。两种方法检测的血小板反应性均与MACE相关。Logistic回归分析发现,只有VerifyNow可以预测MACE的发生(P=0.01)。VerifyNow检测显示为血小板高反应(HPR)的患者MACE发生率为16%,没有HPR的患者MACE发生率为7%(OR=2.6,95%CI=1.5~4.4,P=0.001)。Multiplate检测显示为HPR的患者MACE发生率为13%,没有HPR的MACE发生率为9%(OR=1.5,95%CI=0.9~2.5,P=0.11)。结论 VerifyNow技术检测血小板功能比Multiplate技术可以更好地预测ACS患者的不良预后。 Objective To investigate the predictive value of two methods of platelet function detection for VerifyNow and Multiplate in patients with acute coronary syndrome(ACS).Methods Verify Now and Multiplate were used to detect the platelet reactivity of patients with ACS.The relationship between platelet reactivity and major adverse cardiovascular events(MACE)was explored,including all-cause death,non fatal myocardial infarction,non fatal stroke,stent thrombosis and revascularization.Results After one year of follow-up for 120 patients with ACS,18 patients(15%)had MACE.The platelet reactivity detected by the two methods was both associated with MACE.Logistic regression analysis found that only VerifyNow could predict the occurrence of MACE(P =0.01).VerifyNow detection showed that the incidence of MACE in patients with high platelet response(HPR)was 16%,and the incidence of MACE without HPR was 7%(OR =2.6,95%CI =1.5-4.4,P =0.001).The incidence of MACE in patients with HPR was 13%,and the incidence of MACE without HPR was 9%(OR =1.5,95%CI =0.9-2.5,P =0.11)without HPR.Conclusion This study demonstrated VerifyNow could predict the adverse outcomes better in patients with ACS than Multiplate.
出处 《临床荟萃》 CAS 2017年第12期1049-1052,共4页 Clinical Focus
关键词 急性冠状动脉综合征 血小板 acute coronary syndrome blood platelets
  • 相关文献

参考文献2

二级参考文献33

  • 1马建宏,李广华,周东铭,梁玲,黄美群,欧阳维富,黄锦维,贾雪.血小板聚集功能生物参考区间验证[J].血栓与止血学,2010,16(6):284-286. 被引量:4
  • 2谭大伟,朱平,李小鹰.氯吡格雷抑制血小板功能的两种检测方法比较:血小板聚集实验与血小板膜糖蛋白检测[J].中国组织工程研究与临床康复,2007,11(11):2021-2024. 被引量:11
  • 3Francoise DG, Franck P. The optimal threshold of high post- treatment platelet reactivity could be defined by a point-of-care VerifyNow P2Y12 assay. Online publish-ahead-of-print, 2008,7 : 2186-2187. 被引量:1
  • 4Kyung WP, Kang SH, Kim HS, et al. Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay:additional evidence for the concept of ' smokers' paradox'. Heart, 2012,98 : 1000-1006. 被引量:1
  • 5Gurbel PA, Bliden KP, Zaman KA, et al. Clopidogrel lodading with eptifibatide to arrest the reactivity of platelets:results of the Clopidogrel Loading With Eptifibatide To Arrest the Reactivity of Platelets ( CLEAR PLATELETS ) study. Circulation, 2005, 111 : 1153-1159. 被引量:1
  • 6King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Pereuta- neous Coronary Intervention: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Up- date the ACC/AHA./SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Com- mittee[ J], Circulation, 2008, 117(2) :261 - 295. 被引量:1
  • 7Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for Coronary Stenting: Response Variability, Drug Resistance, and the Effect of Pretreatment Platelet Reactivity [ J ]. Circulation, 2003, 107 (23) : 2908 -2913. 被引量:1
  • 8Park SJ, Park DW, Kim YH, et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents[ J]. N Engl J Med, 2010, 362(15) :1374 - 1382. 被引量:1
  • 9von Beckerath N, Taubert D, Pogatsa-Murray G, et al. Absorption, metabolization, and antiplatelet effects of 300-, 600% and 900-mg loading doses of clopidogrel : Results of the ISAR-CHOICE ( intra- coronary stenting and antithrombotic regimen : Choose between 3 high oral doses for immediate clopidogrel effect) trial [ J ]. Circulation, 2005, 112(19) :2946 -2950. 被引量:1
  • 10Price MJ, Coleman JL, Steinhubl SR, et al. Onset and offset of platelet inhibition after highdose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers [J]. Am J Cardiol, 2006, 98(5) :681 -684. 被引量:1

共引文献3

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部